 The primary objective is to demonstrate the safety and efficacy of a non-awake implantation method EMG neuromonitoring of a SCS paddle lead as compared to an awake implantation method with local anesthesia and patient feedback.This is a post-market, prospective, multicenter, parallel designed, non-randomized, non-blinded, 6-month study. A minimum of 50 patients will be implanted from up to 4 active sites, coordinated by a single lead investigator. 